Issues and prospects of microRNA-based biomarkers in blood and other body fluids
- PMID: 24830712
- PMCID: PMC6271291
- DOI: 10.3390/molecules19056080
Issues and prospects of microRNA-based biomarkers in blood and other body fluids
Abstract
Cell-free circulating microRNAs (miRNAs) in the blood are good diagnostic biomarker candidates for various physiopathological conditions, including cancer, neurodegeneration, diabetes and other diseases. Since their discovery in 2008 as blood biomarkers, the field has expanded rapidly with a number of important findings. Despite the initial optimistic views of their potential for clinical application, there are currently no circulating miRNA-based diagnostics in use. In this article, we review the status of circulating miRNAs, examine different analytical approaches, and address some of the challenges and opportunities.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Cell-free microRNAs in blood and other body fluids, as cancer biomarkers.Cell Prolif. 2016 Jun;49(3):281-303. doi: 10.1111/cpr.12262. Cell Prolif. 2016. PMID: 27218664 Free PMC article. Review.
-
Toward biosensors for the detection of circulating microRNA as a cancer biomarker: an overview of the challenges and successes.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015 Jul-Aug;7(4):580-92. doi: 10.1002/wnan.1324. Epub 2014 Dec 22. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015. PMID: 25529633 Review.
-
Recent progress toward the use of circulating microRNAs as clinical biomarkers.Arch Toxicol. 2016 Dec;90(12):2959-2978. doi: 10.1007/s00204-016-1828-2. Epub 2016 Sep 1. Arch Toxicol. 2016. PMID: 27585665 Review.
-
Profiling cell-free and circulating miRNA: a clinical diagnostic tool for different cancers.Tumour Biol. 2016 May;37(5):5705-14. doi: 10.1007/s13277-016-4907-3. Epub 2016 Jan 29. Tumour Biol. 2016. PMID: 26831657 Review.
-
Serum microRNAs as non-invasive biomarkers for cancer.Mol Cancer. 2010 Nov 26;9:306. doi: 10.1186/1476-4598-9-306. Mol Cancer. 2010. PMID: 21110877 Free PMC article. Review.
Cited by
-
The Role of GLP-1, GIP, MCP-1 and IGFBP-7 Biomarkers in the Development of Metabolic Disorders: A Review and Predictive Analysis in the Context of Diabetes and Obesity.Biomedicines. 2024 Jan 11;12(1):159. doi: 10.3390/biomedicines12010159. Biomedicines. 2024. PMID: 38255264 Free PMC article. Review.
-
Alarmins and MicroRNAs, a New Axis in the Genesis of Respiratory Diseases: Possible Therapeutic Implications.Int J Mol Sci. 2023 Jan 16;24(2):1783. doi: 10.3390/ijms24021783. Int J Mol Sci. 2023. PMID: 36675299 Free PMC article. Review.
-
Circulating Noncoding RNAs in Pituitary Neuroendocrine Tumors-Two Sides of the Same Coin.Int J Mol Sci. 2022 May 4;23(9):5122. doi: 10.3390/ijms23095122. Int J Mol Sci. 2022. PMID: 35563510 Free PMC article. Review.
-
OncoUroMiR: Circulating miRNAs for Detection and Discrimination of the Main Urological Cancers Using a ddPCR-Based Approach.Int J Mol Sci. 2023 Sep 9;24(18):13890. doi: 10.3390/ijms241813890. Int J Mol Sci. 2023. PMID: 37762193 Free PMC article.
-
Fecal microRNAs as Innovative Biomarkers of Intestinal Diseases and Effective Players in Host-Microbiome Interactions.Cancers (Basel). 2020 Aug 5;12(8):2174. doi: 10.3390/cancers12082174. Cancers (Basel). 2020. PMID: 32764361 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources